| scholarly article | Q13442814 |
| P2093 | author name string | Deryl Troyer | |
| Cameron Anderson | |||
| Mark L Weiss | |||
| Satish Medicetty | |||
| Kevin R McIntosh | |||
| Irene VanderWerff | |||
| Kiran B Seshareddy | |||
| Rita J Weiss | |||
| P2860 | cites work | Matrix cells from Wharton's jelly form neurons and glia | Q44279364 |
| Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall Antigens | Q52005550 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 2865-2874 | |
| P577 | publication date | 2008-08-14 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Immune properties of human umbilical cord Wharton's jelly-derived cells | |
| P478 | volume | 26 |
| Q35373250 | Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model. |
| Q54349527 | Analysis of human auricular cartilage to guide tissue-engineered nanofiber-based chondrogenesis: implications for microtia reconstruction. |
| Q57150066 | Application of Cord Blood and Cord Blood-derived Induced Pluripotent Stem Cells for Cartilage Regeneration |
| Q42593149 | Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety |
| Q38910328 | Bone formation by human umbilical cord perivascular cells |
| Q39879492 | CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells |
| Q50737566 | Capacity of human umbilical cord-derived mesenchymal stem cells to differentiate into sweat gland-like cells: a preclinical study. |
| Q37800141 | Cardiac cell therapies: the next generation |
| Q41015957 | Cardioprotective Effects of Wharton Jelly Derived Mesenchymal Stem Cell Transplantation in a Rodent Model of Myocardial Injury. |
| Q38344424 | Cellular therapies based on stem cells and their insulin-producing surrogates: a 2015 reality check |
| Q24630772 | Cellular treatments for spinal cord injury: the time is right for clinical trials |
| Q89612980 | Centella asiatica (L.)-Neurodifferentiated Mesenchymal Stem Cells Promote the Regeneration of Peripheral Nerve |
| Q53479327 | Characterization of HLA-G and Related Immunosuppressive Effects in Human Umbilical Cord Stroma-Derived Stem Cells. |
| Q50980404 | Chitosan-agarose scaffolds supports chondrogenesis of Human Wharton's Jelly mesenchymal stem cells. |
| Q37783940 | Clinical Application of Stem Cells in the Cardiovascular System |
| Q33578111 | Clinical application of decellularized and lyophilized human amnion/chorion membrane grafts for closing post-laryngectomy pharyngocutaneous fistulas |
| Q38317834 | Common expression of stemness molecular markers and early cardiac transcription factors in human Wharton's jelly-derived mesenchymal stem cells and embryonic stem cells |
| Q35659535 | Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton's Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells |
| Q36702970 | Comparative Evaluation of Human Mesenchymal Stem Cells of Fetal (Wharton's Jelly) and Adult (Adipose Tissue) Origin during Prolonged In Vitro Expansion: Considerations for Cytotherapy |
| Q37713328 | Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration |
| Q55019047 | Comparison of Immunological Characteristics of Mesenchymal Stem Cells from the Periodontal Ligament, Umbilical Cord, and Adipose Tissue. |
| Q64880663 | Comparison of capacities to maintain hematopoietic stem cells among different types of stem cells derived from the placenta and umbilical cord. |
| Q39613781 | Comparison of equine bone marrow-, umbilical cord matrix and amniotic fluid-derived progenitor cells. |
| Q40193872 | Comparison of explant-derived and enzymatic digestion-derived MSCs and the growth factors from Wharton's jelly. |
| Q47386516 | Comparison of nucleus pulposus stem/progenitor cells isolated from degenerated intervertebral discs with umbilical cord derived mesenchymal stem cells |
| Q43557059 | Comparison of the ultrastructural and immunophenotypic characteristics of human umbilical cord-derived mesenchymal stromal cells and in situ cells in Wharton's jelly |
| Q48855432 | Construction of bioengineered hepatic tissue derived from human umbilical cord mesenchymal stem cells via aggregation culture in porcine decellularized liver scaffolds |
| Q53085014 | Cotransplantation of human umbilical cord-derived mesenchymal stem cells and umbilical cord blood-derived CD34⁺ cells in a rabbit model of myocardial infarction. |
| Q35825031 | Current View on Osteogenic Differentiation Potential of Mesenchymal Stromal Cells Derived from Placental Tissues |
| Q38210966 | Current status of cell-mediated regenerative therapies for human spinal cord injury |
| Q35726466 | Current stem cell treatments for spinal cord injury |
| Q33958913 | Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice |
| Q42368009 | Defined three-dimensional culture conditions mediate efficient induction of definitive endoderm lineage from human umbilical cord Wharton's jelly mesenchymal stem cells |
| Q36931550 | Developing a New Two-Step Protocol to Generate Functional Hepatocytes from Wharton's Jelly-Derived Mesenchymal Stem Cells under Hypoxic Condition |
| Q58574769 | Differentiation Potential of Human Wharton's Jelly-Derived Mesenchymal Stem Cells and Paracrine Signaling Interaction Contribute to Improve the In Vitro Maturation of Mouse Cumulus Oocyte Complexes |
| Q41520841 | Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold. |
| Q34474179 | Differentiation of human umbilical cord matrix-derived mesenchymal stem cells into germ-like cells |
| Q35628499 | Differentiation of human umbilical cord mesenchymal stem cells into germ-like cells in mouse seminiferous tubules |
| Q36297922 | Direct Comparison of Wharton's Jelly and Bone Marrow-Derived Mesenchymal Stromal Cells to Enhance Engraftment of Cord Blood CD34(+) Transplants |
| Q43964216 | Dopaminergic cells, derived from a high efficiency differentiation protocol from umbilical cord derived mesenchymal stem cells, alleviate symptoms in a Parkinson's disease rodent model |
| Q92623993 | Early Intravenous Infusion of Mesenchymal Stromal Cells Exerts a Tissue Source Age-Dependent Beneficial Effect on Neurovascular Integrity and Neurobehavioral Recovery After Traumatic Cervical Spinal Cord Injury |
| Q36580298 | Effects of Human Umbilical Cord Mesenchymal Stem Cells on Human Trophoblast Cell Functions In Vitro |
| Q91909758 | Effects of the Human Amniotic Membrane on the Cartilage Graft: Prognosis and Absorption in White Rabbits |
| Q42041237 | Efficacy of Human Umbilical Stem Cells Cultured on Polylactic/ Polyglycolic Acid Membrane in the Treatment of Multiple Gingival Recession Defects: a Randomized Controlled Clinical Study |
| Q35853876 | Elimination of allogeneic multipotent stromal cells by host macrophages in different models of regeneration |
| Q37809764 | Emerging topics and new perspectives on HLA-G. |
| Q34433197 | Enhancement of mouse germ cell-associated genes expression by injection of human umbilical cord mesenchymal stem cells into the testis of chemical-induced azoospermic mice |
| Q38815996 | Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells |
| Q52729545 | Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells. |
| Q45329227 | Evaluation of suitable reference gene for real-time PCR in human umbilical cord mesenchymal stem cells with long-term in vitro expansion |
| Q35979655 | Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy. |
| Q33722247 | Exosomes Derived from Akt-Modified Human Umbilical Cord Mesenchymal Stem Cells Improve Cardiac Regeneration and Promote Angiogenesis via Activating Platelet-Derived Growth Factor D |
| Q35708579 | Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury |
| Q64906250 | Exosomes Derived from TIMP2-Modified Human Umbilical Cord Mesenchymal Stem Cells Enhance the Repair Effect in Rat Model with Myocardial Infarction Possibly by the Akt/Sfrp2 Pathway. |
| Q92219344 | Exploring the Most Promising Stem Cell Therapy in Liver Failure: A Systematic Review |
| Q33985593 | Foetal defence against cancer: a hypothesis |
| Q39109728 | Forced expression of indoleamine-2,3-dioxygenase in human umbilical cord-derived mesenchymal stem cells abolishes their anti-apoptotic effect on leukemia cell lines in vitro |
| Q40562142 | Functional recovery after acute intravenous administration of human umbilical cord mesenchymal stem cells in rats with cerebral ischemia-reperfusion injury |
| Q47554530 | Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review). |
| Q34177939 | Gimme shelter: the immune system during pregnancy |
| Q44544821 | Harvesting the potential of the human umbilical cord: isolation and characterisation of four cell types for tissue engineering applications |
| Q52876941 | Heterogeneity of Stem Cells: A Brief Overview. |
| Q64096242 | Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Endometrial Cancer Cell Proliferation and Migration through Delivery of Exogenous miR-302a |
| Q93063229 | Human Umbilical Cord Mesenchymal Stem Cells Alleviate Myocardial Endothelial-Mesenchymal Transition in a Rat Dilated Cardiomyopathy Model |
| Q38408964 | Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting |
| Q39114043 | Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis |
| Q39289071 | Human Wharton's jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice |
| Q53124908 | Human Wharton's jelly stem cell conditioned medium enhances freeze-thaw survival and expansion of cryopreserved CD34+ cells. |
| Q51812638 | Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. |
| Q50472431 | Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells. |
| Q35197832 | Human Wharton's jelly-derived mesenchymal stem cells express oocyte developmental genes during co-culture with placental cells |
| Q48498332 | Human mesenchymal stem cells produce bioactive neurotrophic factors: source, individual variability and differentiation issues |
| Q38189400 | Human term placental cells: phenotype, properties and new avenues in regenerative medicine |
| Q42657769 | Human umbilical cord Wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice. |
| Q39414123 | Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells |
| Q39700462 | Human umbilical cord Wharton's jelly stem cells and its conditioned medium support hematopoietic stem cell expansion ex vivo. |
| Q51149253 | Human umbilical cord derivatives regenerate intervertebral disc. |
| Q53298325 | Human umbilical cord derived mesenchymal stem cells promote interleukin-17 production from human peripheral blood mononuclear cells of healthy donors and systemic lupus erythematosus patients. |
| Q36095585 | Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation |
| Q34949417 | Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture |
| Q36506550 | Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets |
| Q34091455 | Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice |
| Q37372219 | Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AβPP/PS1 transgenic mouse model |
| Q90116059 | Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo: From biological characteristics to therapeutic mechanisms |
| Q46007124 | Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. |
| Q41558644 | Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats |
| Q38332930 | Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy |
| Q37372115 | Human umbilical cord mesenchymal stromal cells exhibit immature nucleus pulposus cell phenotype in a laminin-rich pseudo-three-dimensional culture system |
| Q39834990 | Human umbilical cord mesenchymal stromal cells in regenerative medicine |
| Q90465459 | Human umbilical cord-derived mesenchymal stem cells ameliorate the enteropathy of food allergies in mice |
| Q35053792 | Human umbilical mesenchymal stem cells-seeded bladder acellular matrix grafts for reconstruction of bladder defects in a canine model |
| Q53443562 | Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect. |
| Q34751229 | Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age |
| Q49587686 | Immunological impact of Wharton's Jelly mesenchymal stromal cells and natural killer cell co-culture |
| Q34224955 | Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. |
| Q35166506 | Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells |
| Q52927174 | Immunosuppressive properties of Wharton's jelly-derived mesenchymal stromal cells in vitro. |
| Q43102091 | Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. |
| Q37483567 | In Vitro Characterization of Human Mesenchymal Stem Cells Isolated from Different Tissues with a Potential to Promote Complex Bone Regeneration. |
| Q40477098 | In vitro differentiation process of human Wharton's jelly mesenchymal stem cells to male germ cells in the presence of gonadal and non-gonadal conditioned media with retinoic acid. |
| Q50266845 | In vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells |
| Q47915655 | Induction of dopaminergic neurons from human Wharton's jelly mesenchymal stem cell by forskolin |
| Q50673940 | Integration properties of Wharton's jelly-derived novel mesenchymal stem cells into ventricular slices of murine hearts. |
| Q52719694 | Interleukin-1 receptor antagonist-mediated neuroprotection by umbilical cord-derived mesenchymal stromal cells following transplantation into a rodent stroke model. |
| Q37337836 | Intracerebral and Intravenous Transplantation Represents a Favorable Approach for Application of Human Umbilical Cord Mesenchymal Stromal Cells in Intracerebral Hemorrhage Rats. |
| Q35688535 | Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial |
| Q49200792 | Intrauterine xenotransplantation of human Wharton jelly-derived mesenchymal stem cells into the liver of rabbit fetuses: A preliminary study for in vivo expression of the human liver genes. |
| Q41056469 | Intrinsic Variability Present in Wharton's Jelly Mesenchymal Stem Cells and T Cell Responses May Impact Cell Therapy |
| Q33872003 | Isolation and Characterization of Human Mesenchymal Stem Cells Derived from Human Umbilical Cord Wharton's Jelly and Amniotic Membrane |
| Q30463541 | Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system |
| Q37372524 | Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells |
| Q40563883 | Isolation, characterization and immunomodulatory-associated gene transcription of Wharton's jelly-derived multipotent mesenchymal stromal cells at different trimesters of cow pregnancy |
| Q51870888 | Isolation, proliferation, cytogenetic, and molecular characterization and in vitro differentiation potency of canine stem cells from foetal adnexa: a comparative study of amniotic fluid, amnion, and umbilical cord matrix. |
| Q34903281 | Low immunogenicity of neural progenitor cells differentiated from induced pluripotent stem cells derived from less immunogenic somatic cells |
| Q98463504 | Magnetic resonance imaging of umbilical cord stem cells labeled with superparamagnetic iron oxide nanoparticles: effects of labelling and transplantation parameters |
| Q28536701 | Malignant transformation potentials of human umbilical cord mesenchymal stem cells both spontaneously and via 3-methycholanthrene induction |
| Q36601536 | Manufacturing of Human Umbilical Cord Mesenchymal Stromal Cells on Microcarriers in a Dynamic System for Clinical Use. |
| Q45712380 | Marrow stromal stem cell autologous transplantation in denervated fracture healing: an experimental study in rats. |
| Q42103653 | Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? |
| Q35624272 | Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS). |
| Q37809081 | Mesenchymal Stem Cells: Mechanisms of Inflammation |
| Q38759497 | Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte-Induced Lysis |
| Q92630103 | Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine |
| Q22305707 | Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell |
| Q37576616 | Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review |
| Q59790772 | Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review |
| Q98163678 | Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis |
| Q35240668 | Mesenchymal stem cells: from experiment to clinic |
| Q37512295 | Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications. |
| Q90327731 | Mesenchymal stromal cells as a potential therapeutic for neurological disorders |
| Q35893660 | Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study. |
| Q89699776 | Multipotency of mouse trophoblast stem cells |
| Q34673909 | Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells |
| Q90482425 | Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches |
| Q35829154 | Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study. |
| Q34038421 | Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo |
| Q36839728 | Naïve rat umbilical cord matrix stem cells significantly attenuate mammary tumor growth through modulation of endogenous immune responses. |
| Q38207603 | Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials |
| Q34992307 | Non-random tissue distribution of human naïve umbilical cord matrix stem cells |
| Q33456591 | Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. |
| Q59792176 | Osteogenic Induction of Wharton's Jelly-Derived Mesenchymal Stem Cell for Bone Regeneration: A Systematic Review |
| Q59790769 | Overexpression of apelin in Wharton' jelly mesenchymal stem cell reverses insulin resistance and promotes pancreatic β cell proliferation in type 2 diabetic rats |
| Q37904841 | Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion |
| Q34991991 | Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone |
| Q36216394 | Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study |
| Q41672221 | Placenta-derived multipotent cells have no effect on the size and number of DMH-induced colon tumors in rats |
| Q53146467 | Platelet-derived growth factor promotes the proliferation of human umbilical cord-derived mesenchymal stem cells. |
| Q37203386 | Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues |
| Q57299820 | Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem Cells |
| Q35113901 | Preclinical studies with umbilical cord mesenchymal stromal cells in different animal models for muscular dystrophy |
| Q38960172 | Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model |
| Q33528988 | Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially |
| Q37140023 | Promising cellular therapeutics for prevention or management of graft-versus-host disease (a review). |
| Q51854135 | Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity. |
| Q52603658 | Recent Advances: Decoding Alzheimer's Disease With Stem Cells. |
| Q38568116 | Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells |
| Q34138063 | Regenerative stromal cell therapy in allogeneic hematopoietic stem cell transplantation: current impact and future directions |
| Q37651471 | Repair of Osteochondral Defects Using Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells in a Rabbit Model. |
| Q55269599 | Repair of articular cartilage defects with intra-articular injection of autologous rabbit synovial fluid-derived mesenchymal stem cells. |
| Q30369907 | Replication of influenza A virus in swine umbilical cord epithelial stem-like cells. |
| Q42954387 | Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair. |
| Q58712256 | Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury |
| Q47751965 | Role of Human Wharton's Jelly Derived Mesenchymal Stem Cells (WJ-MSCs) for Rescue of d-Galactosamine Induced Acute Liver Injury in Mice |
| Q27304945 | Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration |
| Q89719257 | Shockwave Therapy Combined with Autologous Adipose-Derived Mesenchymal Stem Cells Is Better than with Human Umbilical Cord Wharton's Jelly-Derived Mesenchymal Stem Cells on Knee Osteoarthritis |
| Q38540635 | Standardizing Umbilical Cord Mesenchymal Stromal Cells for Translation to Clinical Use: Selection of GMP-Compliant Medium and a Simplified Isolation Method |
| Q50098011 | Stem Cell Therapy for Articular Cartilage Repair: Review of the Entity of Cell Populations Used and the Result of the Clinical Application of Each Entity. |
| Q27028106 | Stem cell sources for vascular tissue engineering and regeneration |
| Q36683536 | Stem cells for reprogramming: could hUMSCs be a better choice? |
| Q38479106 | Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and reality |
| Q91688640 | The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells |
| Q92029579 | The cell-based approach in neurosurgery: ongoing trends and future perspectives |
| Q53348481 | The effect of extended passaging on the phenotype and osteogenic potential of human umbilical cord mesenchymal stem cells. |
| Q42173034 | The effects of human Wharton's jelly cell transplantation on the intervertebral disc in a canine disc degeneration model |
| Q37310625 | The immune boundaries for stem cell based therapies: problems and prospective solutions. |
| Q39468118 | The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells |
| Q37122422 | The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure |
| Q38066801 | The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord |
| Q89737509 | Therapeutic Potential of Wharton's Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges |
| Q37777093 | Therapeutic Potentials of Mesenchymal Stem Cells Derived from Human Umbilical Cord |
| Q90288589 | Therapeutic effect of mesenchymal stem cells derived from human umbilical cord in rabbit temporomandibular joint model of osteoarthritis |
| Q50213447 | Therapeutic effects of Wharton jelly-derived mesenchymal stem cells on rat abortion models |
| Q48679443 | Therapeutic potential of human umbilical cord blood mesenchymal stem cells on erectile function in rats with cavernous nerve injury |
| Q24612869 | Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis |
| Q21261301 | Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma |
| Q55317575 | Three-Dimensional Bioreactor Technologies for the Cocultivation of Human Mesenchymal Stem/Stromal Cells and Beta Cells. |
| Q51000940 | Three-dimensional spheroid culture of human umbilical cord mesenchymal stem cells promotes cell yield and stemness maintenance. |
| Q40054920 | Tissues Derived From Reprogrammed Wharton's Jelly Stem Cells of the Umbilical Cord Provide an Ideal Platform to Study the Effects of Glucose, Zika Virus, and Other Agents on the Fetus |
| Q90360790 | Topical Application of Human Wharton's Jelly Mesenchymal Stem Cells Accelerates Mouse Sciatic Nerve Recovery and is Associated with Upregulated Neurotrophic Factor Expression |
| Q30666626 | Transplantation of human Wharton's jelly-derived mesenchymal stem cells highly expressing TGFβ receptors in a rabbit model of disc degeneration |
| Q37995017 | Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives |
| Q35844400 | Transplanted Umbilical Cord Mesenchymal Stem Cells Modify the In Vivo Microenvironment Enhancing Angiogenesis and Leading to Bone Regeneration |
| Q38243207 | Treatment of spinal cord injury: a review of engineering using neural and mesenchymal stem cells |
| Q26798214 | Umbilical Cord Tissue-Derived Cells as Therapeutic Agents |
| Q28067100 | Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy |
| Q39635182 | Umbilical cord matrix derived mesenchymal stem cells can change the cord blood transplant scenario. |
| Q35097799 | Umbilical cord mesenchymal stromal cells affected by gestational diabetes mellitus display premature aging and mitochondrial dysfunction |
| Q39822564 | Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties |
| Q40627899 | Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling. |
| Q47582397 | Umbilical cord-derived mesenchymal stem cell transplantation for treating elderly vascular dementia |
| Q33576929 | Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars |
| Q38207604 | Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility |
| Q53110918 | Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources. |
| Q64967044 | Viable cryopreserved umbilical tissue (vCUT) reduces post-operative adhesions in a rabbit abdominal adhesion model. |
| Q39010662 | Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review |
| Q28083027 | Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease |
| Q50577170 | Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model. |
| Q35226718 | Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance |
| Q37620389 | Wharton's jelly stromal cells as potential delivery vehicles for cancer therapeutics |
| Q37007214 | Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications |
| Q37802776 | Wharton’s Jelly Mesenchymal Stem Cells as Candidates for Beta Cells Regeneration: Extending the Differentiative and Immunomodulatory Benefits of Adult Mesenchymal Stem Cells for the Treatment of Type 1 Diabetes |
| Q41081026 | What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells? |
Search more.